Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) - Effects of Proton Pump Inhibitors (PPI): Retrospective Analysis

被引：0
|
作者：
Tskhakaia, Irakli [1 ]
Lau, Arthur [1 ]
机构：
[1] Jefferson Einstein Hosp, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2441
引用
收藏
页码：4950 / 4952
页数：3
相关论文
共 50 条
  • [31] Severity of Gastroesophageal Reflux, but Not the Use of Proton Pump Inhibitors, Is Associated with Radiographic Progression of Interstitial Lung Disease in Systemic Sclerosis
    Volkmann, Elizabeth
    Tashkin, Donald
    Leng, Mei
    Kim, Grace
    Goldin, Jonathan
    Roth, Michael
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3867 - 3869
  • [32] Esomeprazole versus other proton-pump inhibitors (PPI): Clinical and cost effectiveness analysis
    Kaczor, M.
    Becla, L.
    Pawlik, D.
    Dardzinski, W.
    Walczak, J.
    Nogas, G.
    Wojcik, R.
    Zespol-Instytutu, A.
    VALUE IN HEALTH, 2006, 9 (06) : A242 - A242
  • [33] Critical analysis of the effects of proton pump inhibitors on inflammatory bowel disease: An updated review
    Goyal, Omesh
    Goyal, Manjeet Kumar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (37)
  • [34] Effects of Proton Pump Inhibitors in Patients with Laryngopharyngeal Reflux Disease
    Chiba, Toshimi
    Kudara, Norihiko
    Abiko, Yukito
    Endo, Masaki
    Suzuki, Kazuyuki
    Sugai, Tamotsu
    Ishijima, Ken
    Fukuda, Koji
    Yamazaki, Kazuharu
    Sato, Hiroaki
    HEPATO-GASTROENTEROLOGY, 2011, 58 (110) : 1580 - 1582
  • [35] A Retrospective Analysis of the Effect of Long-Term Proton Pump Inhibitor (PPI) Use on the Prevalence of Ischemic Heart Disease (IHD)
    Syed, Aslam R.
    Wolfe, Matthew R.
    Wolfe, M. M.
    GASTROENTEROLOGY, 2016, 150 (04) : S216 - S216
  • [36] A MULTINATIONAL SURVEY TO IDENTIFY THE CLINICIANS PERSPECTIVES CONCERNING PROTON PUMP INHIBITORS IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Bandini, Giulia
    Alunno, Alessia
    Pinheiro, Filipe Oliveira
    Campochiaro, Corrado
    Galetti, Ilaria
    Cerinic, Pietro Matucci
    Ruaro, Barbara
    Pignone, Alberto Moggi
    Dagna, Lorenzo
    Cerinic, Marco Matucci
    McMahan, Zsuzsanna H.
    Hughes, Michael
    RHEUMATOLOGY, 2024, 63 : I94 - I94
  • [37] A multinational survey to identify the clinicians perspectives concerning proton pump inhibitors in patients with systemic sclerosis
    Bandini, Giulia
    Alunno, Alessia
    Pinheiro, Filipe Oliveira
    Campochiaro, Corrado
    Galetti, Ilaria
    Cerinic, Pietro Matucci
    Ruaro, Barbara
    Pignone, Alberto Moggi
    Dagna, Lorenzo
    Cerinic, Marco Matucci
    McMahan, Zsuzsanna H.
    Hughes, Michael
    RHEUMATOLOGY, 2024, 63
  • [38] Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients
    Yang, Hsun
    Juang, Shiun-Yang
    Liao, Kuan-Fu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 147 : 67 - 75
  • [39] Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
    Arora, Pradeep
    Gupta, Anu
    Golzy, Mojgan
    Patel, Nilang
    Carter, Randolph L.
    Jalal, Kabir
    Lohr, James W.
    BMC Nephrology, 2016, 17
  • [40] Proton Pump Inhibitors and Chronic Kidney Disease: Causation or Another False Alarm?
    Bjorkman, David J.
    GASTROENTEROLOGY, 2017, 153 (03) : 638 - 640
12345